CSI Market
Sign In | Register

Amgen Inc (AMGN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AMGN Annual Cash Flow →
Quarterly cash flow trends provide additional context on Amgen Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income4,194.00
Depreciation & amortization2,670.00
Amortization of Other Assets1,800.00
Impairments on assets0.00
Impairment of Long-Lived Assets to be Disposed of0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories13.00
Other non-cash items0.00
Sale of Business0.00
Share-based Compensation240.00
Income (Loss) from Equity Method Investments0.00
Stock compensation plans90.00
Increase Decrease In Noncurrent Tax Liability71.00
Increase Decrease In Sales Incentives And Allowance-839.00
Income taxes0.00
Unrealized Gain (Loss) on Investments-301.00
Increase (Decrease) in Accounts Receivable680.00
Increase (Decrease) in Accounts Payable501.00
Increase (Decrease) in Accrued Liabilities-58.00
Deferred revenue0.00
Increase (Decrease) in Deferred Income Taxes0.00
Other Working Capital215.00
Other Noncash Income (Expense)-8.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-3,845.00
Discontinued operations0.00
Net Cash flow from Operating Activities6,191.00
Investing Activities
Capital Expenditures-1,225.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Marketable Securities0.00
Proceeds from sales of other investments0.00
Increase (Decrease) of Restricted Investments0.00
Minority interest 0.00
Proceeds from sale of investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Note receivable0.00
Payments for (Proceeds from) Other Investing Activities-60.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1,285.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-233.00
Long-term debt - borrowings3,964.00
Long-term debt - repayments-833.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-224.00
Other net0.00
Payments of Contingent Consideration Obligation-
Dividends paid to minority interests0.00
Dividends paid-2,720.00
Net Cash Flow from Financing Activities-46.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow4,966.00
Total Cash Flow4,860.00
4 historic quarters locked

Sign in to unlock the full Amgen Inc cash flow history.

Sign In Create Free Account

About Amgen Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000318154-26-000126

Figures are derived from filed reports and may be restated. Historical data is subject to revision.